MedPath

Computerised Intervention/Treatment for Adolescent Depression and Low Mood:

Not Applicable
Completed
Conditions
Depression
Registration Number
NCT02186730
Lead Sponsor
Leeds and York Partnership NHS Foundation Trust
Brief Summary

This study forms the second phase of previous work to examine the effectiveness of computerised Cognitive Behaviour Therapy (cCBT) to treat adolescents with low mood/depression.

Depression affects around 2% of adolescents. Antidepressants are not recommended for this age range as a first line treatment because of concerns about their usefulness and side effects. Government guidelines have supported using Cognitive Behaviour Therapy (CBT), which is effective and one of the main treatments recommended for depression. It has been suggested that computerised versions of CBT (cCBT) may be effective for treating depression in young people who may prefer this to seeing a therapist face-to-face, but little research exists to date to support this. This study examines the feasibility of running a large scale randomised controlled trial (RCT) to compare a promising cCBT program (Stressbusters) with self-help websites for adolescents with low mood and depression (LMD).

Eligible and consenting participants will complete several questionnaires to assess their mood before being randomly assigned to either cCBT (Stressbusters) or equivalent access to selected websites providing self help for LMD. Participants will complete further mood questionnaires 4 and 12 months after treatment completion/withdrawal. We have already recruited 97 individuals to this trial but aim to recruit a further 48 participants to collect further information.

We are also keen to find out whether sending participants text messages before sessions and around follow up periods will increase attendance/completion. Therefore all trial participants will receive text messages from the research team during their participation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  • 12 to 18 years
  • Low mood/depression
  • co-morbid physical illness or co-morbid non-psychotic functional disorders, such as anxiety
Exclusion Criteria
  • Suicidality
  • Postnatally depressed
  • Suffering psychotic symptoms

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Changes on the Short Beck Depression Inventory from baseline to 4 and 12 months follow upbaseline, 4 months follow up, 12 months follow up
Secondary Outcome Measures
NameTimeMethod
The Short Mood and Feelings Questionnaireup to 8 weeks
Changes in health status measured by the EQ-5D-Y from baseline to 4 and 12 months follow upBaseline, 4 months follow up, 12 months follow up
Changes in health status measured by the HUI2 from baseline to 4 and 12 months follow upBaseline, 4 months follow up and 12 months follow up
Changes on the Mood and Feelings Questionnaire from baseline to 4 and 12 months follow upBaseline, 4 months follow up, 12 months follow up
Changes on the Spence Children's Anxiety Scale from baseline to 4 and 12 months follow upBaseline, 4 months follow up and 12 months follow up
The number of health services used by participants between baseline, 4 months and 12 months follow upBaseline, 4 months follow up, 12 months follow up

Trial Locations

Locations (1)

Limetrees Child Adolescent and Family Unit

🇬🇧

York, North Yorkshire, United Kingdom

Limetrees Child Adolescent and Family Unit
🇬🇧York, North Yorkshire, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.